A Health Podyssey · 2026-07-14 · 24 min
A Health Podyssey is on vacation in July. We will return with new episodes in August 2026. This episode originally aired on April 14, 2026. Health Affairs ' Rob Lott interviews James Robinson of the University of California Berkeley about his recent paper exploring most favored nation drug pricing , weighing its feasibility, likely effects on drug launch prices, and implications for global pharmaceutical innovation and investment. Order the April 2026 issue of Health Affairs .
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
Advancing Health Equity in a Time of Retrenchment: On Equity, Value, and the Work AheadLeadership Conversations · on Health equity61 / 100
The Intersection Between For-Profit and Non-Profit Organizations and Leadership, with Tom UlbrichHuman Capital Leadership · on social innovation46 / 100
046_Building Trust and Partnership for Health Equity with Dr. Philip AlbertiExcellence In Healthcare Podcast · on Health equity
81: From Nothing to a Billion: The Leadership Playbook They Don’t Teach You w/ Harry L AllenNo Limit Leadership · on covid-19
We're all only one new decision from massive change. Discipline that shapes the lifestyle by Chip EichelbergerBelkins Podcast · on covid-19
Catching Up with Trends in COVID and Telemed - Janet Young and Chris GagenHealthcare on the Rocks · on covid-19Health Care Acquisitions: What Happens to Patient Care Intensity?91 / 100How ACO Conveners Are Changing the Medicare Shared Savings Program (MSSP) Behind the Scenes82 / 100Why Medicare’s Hospital Wage Index Exceptions Jumped 60%85 / 100Private Equity in Primary Care: Costs, Care, and Impact90 / 100Inside CMS: How Medicare Innovation Models Are Working to Lower Costs & Scale Digital Health88 / 100